APTO•benzinga•
Aptose Receives Fast Track Designation For HM43239 In Relapsed/Refractory AML Patients And FLT3 Mutation
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 4, 2022 by benzinga